TREAT Asia Salutes Women in HIV Science
In conjunction with this year’s International Day of Women and Girls in Science on February 11, the International AIDS Society (IAS) has honored some of the many women dedicated to studying how to prevent, manage, and cure HIV and AIDS. Two of the researchers are current or former TREAT Asia network investigators. Dr. Tavitiya Sudjaritruk is one of the five scientists profiled on the IAS website, and Dr. Jintanat Ananworanich is one of the three featured in the Journal of the American AIDS Society (JIAS).
Dr. Tavitiya Sudjaritruk
Dr. Tavitiya SudjaritrukDr. Tavitiya Sudjaritruk is the site principal investigator for the TREAT Asia Pediatric HIV Observational Database (TApHOD) study at Chiang Mai University, Thailand. Dr. Sudjaritruk has led multiple pediatric and adolescent HIV studies with support from TREAT Asia, including on tuberculosis, the impact of HIV and ART on bone health, the incidence of post-suppression viral rebound, the impact of the frequency of viral load monitoring on treatment outcome, the consequences of persistent viremia, and peripheral artery disease. In 2014, she became the first researcher in Asia to receive a grant from IAS’s Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) for her study of nonalcoholic fatty liver disease in perinatally infected young people. She also received the best oral presentation award at the International Workshop on HIV Pediatrics at AIDS 2016. Dr. Sudjaritruk is currently leading an NIH IeDEA-funded study to evaluate depression and anxiety in Thai adolescents with HIV.
Dr. Jintanat Ananworanich
Dr. Jintanat AnanworanichTREAT Asia salutes Dr. Jintanat Ananworanich, who was recently selected to chair amfAR’s Scientific Advisory Committee. Dr. Ananworanich, the Associate Director for Therapeutics Research at the US Military HIV Research Program (MHRP) and Co-director of SEARCH, The Thai Red Cross AIDS Research Centre, is leading some of the most exciting adult and pediatric HIV cure research occurring in the world today. Her research focuses on people with acute or early infection. A former TREAT Asia principal investigator at our HIV-NAT pediatric site in Bangkok, Thailand, Dr. Ananworanich is currently evaluating strategies aimed at inducing HIV remission, such as therapeutic vaccines and broadly neutralizing antibodies. She has led more than 100 studies and has more than 250 publications on HIV. She is currently the principal investigator on the MHRP/National Institute of Allergy and Infectious Diseases (NIAID)-funded acute HIV infection study, RV254/SEARCH 010.